Cargando…
Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in underst...
Autores principales: | Williams, Bianca, Löbel, Wiebke, Finklea, Ferdous, Halloin, Caroline, Ritzenhoff, Katharina, Manstein, Felix, Mohammadi, Samira, Hashemi, Mohammadjafar, Zweigerdt, Robert, Lipke, Elizabeth, Cremaschi, Selen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390976/ https://www.ncbi.nlm.nih.gov/pubmed/32793579 http://dx.doi.org/10.3389/fbioe.2020.00851 |
Ejemplares similares
-
Process control and in silico modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors
por: Manstein, Felix, et al.
Publicado: (2021) -
High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling
por: Manstein, Felix, et al.
Publicado: (2021) -
Vascularization of Engineered Spatially Patterned Myocardial Tissue Derived From Human Pluripotent Stem Cells in vivo
por: Wanjare, Maureen, et al.
Publicado: (2019) -
Induced pluripotent stem cell-based therapies for organ fibrosis
por: Cheng, Wei, et al.
Publicado: (2023) -
Scaffolds of Macroporous Tannin Spray With Human-Induced Pluripotent Stem Cells
por: Yang, Yongbo, et al.
Publicado: (2020)